Aimmune Therapeutics
United States
acquired
acquired
Stage
About
Aimmune Therapeutics develops treatments for food allergies aimed at reducing allergic reactions and improving patient quality of life.
Explore Aimmune Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.